2018
DOI: 10.1016/j.cell.2018.03.030
|View full text |Cite
|
Sign up to set email alerts
|

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

Abstract: Antibodies to the hemagglutinin (HA) and neuraminidase (NA) glycoproteins are the major mediators of protection against influenza virus infection. Here, we report that current influenza vaccines poorly display key NA epitopes and rarely induce NA-reactive B cells. Conversely, influenza virus infection induces NA-reactive B cells at a frequency that approaches (H1N1) or exceeds (H3N2) that of HA-reactive B cells. NA-reactive antibodies display broad binding activity spanning the entire history of influenza A vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

10
348
2
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 308 publications
(361 citation statements)
references
References 53 publications
10
348
2
1
Order By: Relevance
“…This is consistent with 277 previous studies that have directly observed a neuraminidase directed antibody response following 278 vaccination [23,27]. Given the lack of protection demonstrated and questions about the quality of 279 vaccine induced neuraminidase antibody [28], it is clear that more work needs to be done to understand 280 antigenic drift of the neuraminidase, and how and when anti-neuraminidase antibodies mediate 281 protection. 282…”
Section: Discussion 234supporting
confidence: 79%
“…This is consistent with 277 previous studies that have directly observed a neuraminidase directed antibody response following 278 vaccination [23,27]. Given the lack of protection demonstrated and questions about the quality of 279 vaccine induced neuraminidase antibody [28], it is clear that more work needs to be done to understand 280 antigenic drift of the neuraminidase, and how and when anti-neuraminidase antibodies mediate 281 protection. 282…”
Section: Discussion 234supporting
confidence: 79%
“…Antibodies are correlates of protection in the majority of currently licensed vaccines and have been shown to also convey protection against HIV, malaria and influenza [44][45][46]. However, for several reasons including quickly mutating antigens and the parallel display of multiple epitopes, these diseases still evade efficient vaccination.…”
Section: Manipulating Gc Selection Processesmentioning
confidence: 99%
“…Antibodies measured by the HI assay are an established correlate of protection for influenza virus infection [10,20,21]. Neutralizing antibodies against the dominant surface proteins, hemagglutinin (HA) and neuraminidase (NA), can target different sites on them, and the specificity of the antibody response appears to change with immune history and age [22,23,24,25,26]. HI assays measure antibodies to HA but not NA, and they disproportionately measure anti-HA antibodies that attach near the receptor binding site toward the top of the HA globular domain.…”
Section: Homosubtypic Protection Correlates Better With Anti-ha Antibmentioning
confidence: 99%